Access 16 Verified Employees Profiles for Orphai TherapeuticsUnlock Free Contacts Now
About
At OrphAI Therapeutics, we are focused on identifying and developing innovative therapeutics. Our current clinical stage drug candidates target Group 1 and Group 3 Pulmonary Hypertension and bronchiolitis obliterans syndrome post lung transplant.